This site is intended for Healthcare Professionals only.

RP compliance is mandatory, not optional: PDA


Share post:

The Pharmacists’ Defence Association (PDA) has advised its member to check their understanding of what activities can legitimately take place when no RP is signed in at the pharmacy or the absence provisions are used.

The advisory to its member was followed after noticing a considerable talk on social media about compliance with the Responsible Pharmacist (RP) regulations which also included unauthorized activity occurring when no RP is signed in.

“There have been comments made that some pharmacists and pharmacy team members may fear repercussions from challenging or whistle-blowing about such behavior,” PDA said.

“To assist members with the interpretation of the RP regulations, the PDA has made available a legal briefing note about the RP regulations produced by a specialist pharmacy regulation law firm.”

It further added: “Non-compliance with the regulations by pharmacy teams should be reported to the pharmacy superintendent.”

The PDA appreciates that the 2021 Safer Pharmacies Survey showed that only 10.6% of respondents always felt able to raise concerns (only 6.1% of those working for CCA members), however, the PDA has significant experience in supporting members who wish to make protected disclosures (whistle-blowing).

“If members feel they are having undue pressure placed upon them by managers to compromise professional standards when acting as the RP, or they have reason to believe that the RP regulations are not being followed at other times, then they can contact the PDA Service Centre for advice and support.”


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...